Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020535
Filing Date
2021-04-26
Accepted
2021-04-26 16:16:14
Documents
7
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 2021 DEF 14A arvn-def14a_20210608.htm DEF 14A 1608907
2 GRAPHIC gvcim3y3z4ys000002.jpg GRAPHIC 50501
3 GRAPHIC gvcim3y3z4ys000005.jpg GRAPHIC 89564
4 GRAPHIC gvcim3y3z4ys000001.jpg GRAPHIC 50501
5 GRAPHIC gvcim3y3z4ys000006.jpg GRAPHIC 76984
6 GRAPHIC gvcim3y3z4ys000003.jpg GRAPHIC 21709
7 GRAPHIC gvcim3y3z4ys000004.jpg GRAPHIC 23837
  Complete submission text file 0001564590-21-020535.txt   2042144
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38672 | Film No.: 21854003
SIC: 2834 Pharmaceutical Preparations